Markets.com Logo

GLYC

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.2378$
  • Previous Close
    0.2286$
  • 52 Week Change
    0.49$
  • Day Range
    0.01$
  • 52 Week High/Low
    0.1406$ - 0.63$
  • Dividend Per Share
    --
  • Market cap
    14 765 K$
  • EPS
    -0.04
  • Beta
    1.699
  • Volume
    --

About

GLYC.US represents GlycoMimetics, Inc., a biotechnology company focused on discovering and developing glycomimetic drugs for various diseases, including cancer and inflammatory conditions. The company's lead drug candidate is uproleselan, a novel E-selectin antagonist being developed for acute myeloid leukemia (AML). GlycoMimetics aims to address unmet medical needs by targeting carbohydrate biology, developing innovative therapies that mimic or inhibit the functions of carbohydrates involved in disease processes. The stock trades on the NASDAQ exchange under the ticker symbol GLYC.
Forex Market Analysis: What Factors Are Influencing the GBP/AED Exchange Rate in 2026?

Forex Market Analysis: What Factors Are Influencing the GBP/AED Exchange Rate in 2026?

Frances Wang|--
Commodity market today: UAE to exit OPEC on May 1, how will this impact global oil prices?

Commodity market today: UAE to exit OPEC on May 1, how will this impact global oil prices?

Frances Wang|--
Crypto market analysis: AAVE price AAVE/ZAR surges, what’s happening with the crypto market in South Africa?

Crypto market analysis: AAVE price AAVE/ZAR surges, what’s happening with the crypto market in South Africa?

Ghko B|--
Liquidity, Costs, and Execution: A Comparative Analysis of JSE and A2X for ZA Traders

Liquidity, Costs, and Execution: A Comparative Analysis of JSE and A2X for ZA Traders

Ghko B|--
ETH Price Prediction 2026: Ethereum Sees $14.5B in 24-Hour Volume, What’s Next for ETHUSD?

ETH Price Prediction 2026: Ethereum Sees $14.5B in 24-Hour Volume, What’s Next for ETHUSD?

Ghko B|--
Mag 7 stocks analysis: What’s going on with Nvidia, Microsoft, Meta and the Rest?

Mag 7 stocks analysis: What’s going on with Nvidia, Microsoft, Meta and the Rest?

Ghko B|--

Oil Market Paradox: Geopolitical Tensions vs. Stable Prices

Ava Grace|--

Factors

GlycoMimetics' (GLYC.US) stock price is influenced by various factors, primarily centered around its clinical development pipeline and financial performance. Clinical Trial Results: Positive data from clinical trials of its drug candidates, particularly rivipansel, can significantly increase the stock price. Conversely, negative or inconclusive results can lead to a decrease.

Regulatory Approvals: Receipt of FDA approval for any of GlycoMimetics' drug candidates would likely cause a substantial increase in stock price. Delays or rejections can have the opposite effect.

Competition: The competitive landscape within the pharmaceutical industry, specifically concerning drugs targeting similar conditions, affects investor sentiment and the potential market share for GlycoMimetics' products.

Financial Performance: GlycoMimetics' revenue, cash burn rate, and overall financial stability play a critical role. Strong financial results and a healthy cash position instill investor confidence, while losses and potential need for additional funding can depress the stock price.

Partnerships and Collaborations: Entering into partnerships with larger pharmaceutical companies for drug development, manufacturing, or commercialization can positively impact the stock price, signaling validation and potential revenue streams. Conversely, termination of such partnerships can have a negative impact.

Market Conditions: Broader market trends, economic conditions, and investor sentiment toward biotechnology stocks in general can influence GlycoMimetics' stock price, regardless of company-specific news.

Intellectual Property: The strength and protection of GlycoMimetics' patents and intellectual property rights are crucial for maintaining a competitive advantage. Challenges to its patents can create uncertainty and negatively affect the stock price.

Management Team: The experience and reputation of GlycoMimetics' management team can influence investor confidence. Changes in key leadership positions can also impact the stock price.

News and Announcements: Company announcements, press releases, and media coverage related to clinical trials, partnerships, financial results, and other significant events can all affect the stock price.

Analyst Ratings: Recommendations and price targets issued by financial analysts can influence investor perception and trading activity, thereby impacting the stock price.

People Also Watch

Latest news

Forex Market Today: USD/JPY Surges Above 150 as Dollar Strength Returns Amid Fed Rate Outlook

Forex Market Today: USD/JPY Surges Above 150 as Dollar Strength Returns Amid Fed Rate Outlook

Ghko B|--
Q1 2026 Earnings to Watch Today: Coca-Cola (KO) Set to Report Before Market Open

Q1 2026 Earnings to Watch Today: Coca-Cola (KO) Set to Report Before Market Open

Frances Wang|--
Gold Price Today, May 06: XAU/USD Hits Fresh Highs Above $4,600 as Safe-Haven Demand Surges Amid Global Uncertainty

Gold Price Today, May 06: XAU/USD Hits Fresh Highs Above $4,600 as Safe-Haven Demand Surges Amid Global Uncertainty

Ghko B|--

Latest Education Articles

What Is Scalping in Trading? A Practical Guide for CFD Traders

What Is Scalping in Trading? A Practical Guide for CFD Traders

Julian Parker|--
Copy Trading vs Mirror Trading: Key Differences, Risks and Which One Suits CFD Traders?

Copy Trading vs Mirror Trading: Key Differences, Risks and Which One Suits CFD Traders?

Julian Parker|--
What Is Copy Trading and How Does It Work?

What Is Copy Trading and How Does It Work?

Julian Parker|--
Recommended Topics